Articles

A year and a half ago, San Antonio’s Dr. Ralph DeFronzo stood before thousands of doctors and told them the way most treat their diabetic patients just doesn’t work very well and we need to be more aggressive. What we are doing now is just not working. A lengthy paper signed by …

By as early as seven years of age, being obese may raise a child’s risk of future heart disease and stroke, even in the absence of other cardiovascular risk factors such as high blood pressure, according to a new study.…

Doctors at Eastern Virginia Medical School’s Strelitz Diabetes Center have been stalking the culprit responsible for Type 1 diabetes. Now, they are one step closer….

There is a debate over the independent effects of aerobic fitness and body fatness on mortality and disease risks.…

Overeating triggers a molecule once considered to be only involved in detecting and fighting viruses to also destroy normal metabolism, leading to insulin resistance and setting the stage for diabetes….

Major depression raises risks of advanced and severe complications from diabetes, according to a prospective study. These complications include kidney failure or blindness, the result of small vessel damage, as well as major vessel problems leading to myocardial infarction (MI) or stroke.…

Consuming two or more soft drinks per week increased the risk of developing pancreatic cancer by nearly twofold compared to individuals who did not consume soft drinks, according to a report….

A Michigan State University scientist has finally discovered how high blood sugar levels can cause blindness….

Results from January 2007 to December 2007 from the Behavioral Risk Surveillance System (BRFSS), an ongoing telephone survey of US adults on health-risk behaviors and the use of preventative healthcare services related to the leading causes of death and disability in the United States, were reported last week….

Transition Therapeutics announces results of a Phase 2 study of TT-223 (GLP-1 Cpd + Gastrin) in Type 2 diabetes patients. The results show that beta-cells can possibly be generated and/or restored. After a 10 week trial the drug was stopped and 6 months later, the A1c had dropped by 1.13 points.